ABBOTT PARK, Ill., Oct. 11, 2013 /PRNewswire/ -- (NYSE: ABT) - A new study has
found that the use of oral nutritional supplements provided to pediatric
patients during hospitalization was associated with a decrease in length of stay
of 14.8 percent and a decrease in hospital stay costs of $1,768 per patient. The
study, conducted by leading researchers at the University of Southern
California, The Children's Hospital of Philadelphia, Harvard Medical School,
Massachusetts General Hospital, and Precision Health Economics, and supported by
Abbott, is being presented this weekend at the 2013 North American Society for
Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting
The 11-year retrospective study (2000-2010) was analyzed using the Premier
Research Database, which contains data on more than half a million hospitalized
pediatric cases for patients aged 2 to 8 years. This study is the latest in
health economics and outcomes research to illustrate the impact of oral
nutrition supplement use in hospitalized patients.
"Malnutrition in children is associated with poor health outcomes and this is
especially important in the hospitalized child," said Maria Mascarenhas, MD,
associate professor of pediatrics at the Children's Hospital of Philadelphia.
"Nutritional support is a critical component of the clinical management for
pediatric inpatients, but it is often overlooked due to other medical issues."
In the study, investigators were able to determine differences in length of stay
and cost of care by comparing hospital stays in which oral nutritional
supplements were prescribed to hospital stays of similar conditions where oral
nutritional supplements weren't prescribed.
Oral nutritional supplements are dietary food, often in liquid form, that
provide protein, nutrients and calories for added nutrition and energy in one's
"While other studies have examined the use of nutritional supplements in adults,
prior to this study there weren't any that rigorously quantified the impact of
oral nutritional supplements on health economic outcomes in the general
pediatric population," said Darius Lakdawalla, Ph.D., University of Southern
California. "These results suggest that nutritional solutions can be a
cost-effective approach to improving pediatric patients' hospital care."
"Through its leadership in nutrition health economics and outcomes research,
Abbott is demonstrating the potential that nutritional intervention can have for
the health of children and adult patients, and the cost savings for hospitals,"
said Robert H. Miller, Ph.D., divisional vice president, Global Research
&Development and Scientific Affairs for Abbott Nutrition. "This is important in
the midst of the changing healthcare landscape as hospitals seek effective
interventions to help improve patient quality of care and reduce overall costs."
About the Study
The "Impact of Oral Nutrition Supplements on Hospital Outcomes in Pediatric
Patients" study is an 11-year retrospective data analysis assessing the effect
of oral nutritional supplement use on inpatient length of stay and hospital stay
cost in hospitalized children.
The study compared hospital stays where oral nutritional supplements were
provided with similar hospital stays that did not provide oral nutritional
supplements. The difference in the two groups between length of hospital stay
and the cost of treatment were measured.
Length of stay was defined as the number of days of direct patient care (minimum
of one day) from admission to discharge. Hospital stay cost was defined as the
actual costs to treat the patient during the hospitalization.
The retrospective analysis utilized information from more than half a million
pediatric hospitalizations found in the Premier Research Database from
2000-2010, which represents a total of 46 million hospital stays at 460
hospitals across the U.S., or approximately 20 percent of all inpatient
admissions in the U.S.
The full sample consisted of 557,348 inpatient admissions of pediatric patients
aged 2 years to 8 years and focused on oral feeding interventions only.
The matched sample (of patients receiving oral nutritional supplementation and
patients who did not receive oral nutritional supplementation, based on
socio-demographic and health characteristics) included 11,031 total hospital
stays. In addition to propensity score matching, instrumental variables
regression analysis was performed to minimize bias.
About Precision Health Economics
Founded by three renowned health economists from leading universities: Tomas
Philipson; Dana Goldman; and Darius Lakdawalla, Precision Health Economics (PHE)
integrates deep technical expertise with practical insights to bring
intellectual integrity, academic rigor, and a creative approach to the most
challenging problems in healthcare. PHE has offices across the United States and
draws on the research expertise of a network of affiliated academic economists
and clinicians from the world's leading universities. PHE's work straddles the
policy arena and the clinical field, reaching top decision makers to influence
outcomes. For more information, go to www.precisionhealtheconomics.com.
About Abbott Nutrition
For more than 85 years, Abbott Nutrition has been developing and marketing
science-based nutritional products to support the growth, health and wellness of
people of all ages. Internationally recognized brands include the Similac(R)
brand of infant formulas; the Gain(R) brand of growing-up milks; the
PediaSure(R) brand of complete and balanced nutrition for children; and the
Ensure(R) brand of complete and balanced nutrition for adults.
The company is a leader in nutritional products clinically shown to address the
distinct dietary needs of people with serious health conditions or special
nutrient requirements, such as the Glucerna(R) brand of nutrition shakes and
bars for people with diabetes.
Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of healthcare.
With a portfolio of leading, science-based offerings in diagnostics, medical
devices, nutritionals and branded generic pharmaceuticals, Abbott serves people
in more than 150 countries and employs approximately 70,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.